$HAIAF
Healthcare AI Acquisition Corp. Stock $haiaf

$haiaf Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000147793224005453 Filed on September 03, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024 Q1
Revenue		$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$70.75K	$87.53K
YoY Change		-76.42%	-78.0%
Operating Profit	-$413.0K	-$70.75K
YoY Change	43.66%	-76.48%
Interest Expense		$76.21K	$85.23K
YoY Change		-96.42%	-96.39%
% of Operating Profit
Other Income/Expense, Net	$405.4K	$216.4K	-$464.4K
YoY Change	-63.69%	-94.19%	-369.66%
Pretax Income		$145.7K	-$466.7K
YoY Change		-95.74%	106.78%
Income Tax
% Of Pretax Income
Net Earnings	-$7.658K	$145.7K	-$466.7K
YoY Change	-100.92%	-95.74%	106.78%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share		$0.02	-$0.08
COMMON SHARES
Basic Shares Outstanding	591.9K shares	5.391M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments		$210.00	$210.00
YoY Change			-99.86%
Cash & Equivalents	$212.00	$211.00
Short-Term Investments
Other Short-Term Assets		$40.50K	$60.75K
YoY Change			-61.82%
Inventory
Prepaid Expenses	$20.25K	$40.50K
Receivables
Other Receivables
Total Short-Term Assets	$20.46K	$40.71K	$60.96K
YoY Change	5.26%	9.1%	-80.58%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$6.750M	$6.674M
YoY Change		-63.71%	-97.04%
Other Assets
YoY Change
Total Long-Term Assets	$6.827M	$6.750M	$6.674M
YoY Change	4.8%	-63.72%	-97.04%
TOTAL ASSETS
Total Short-Term Assets	$20.46K	$40.71K	$60.96K
Total Long-Term Assets	$6.827M	$6.750M	$6.674M
Total Assets	$6.847M	$6.791M	$6.735M
YoY Change	4.8%	-63.57%	-97.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$203.6K	$235.6K	$221.8K
YoY Change	-1.19%	345.37%	293.88%
Deferred Revenue
YoY Change
Short-Term Debt		$216.5K	$216.5K
YoY Change		116.45%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.185M	$792.0K	$741.5K
YoY Change	175.41%	616.34%	247.49%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$876.3K	$1.016M
YoY Change		-53.88%	-91.08%
Total Long-Term Liabilities		$876.3K	$1.016M
YoY Change		-53.88%	-91.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.185M	$792.0K	$741.5K
Total Long-Term Liabilities		$876.3K	$1.016M
Total Liabilities	$1.732M	$1.668M	$1.758M
YoY Change	24.27%	-17.71%	-84.86%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.999M	-$1.991M
YoY Change	5.22%	-19.23%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.712M	-$1.628M	-$1.697M
YoY Change
Total Liabilities & Shareholders Equity	$6.847M	$6.791M	$6.735M
YoY Change	4.8%	-63.57%	-97.02%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$7.658K	$145.7K	-$466.7K
YoY Change	-100.92%	-95.74%	106.78%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities			$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities			0.000
YoY Change
NET CHANGE
Cash From Operating Activities		0.000	0.000
Cash From Investing Activities			0.000
Cash From Financing Activities			0.000
Net Change In Cash		0.000	0.000
YoY Change		-100.0%	-100.0%
FREE CASH FLOW
Cash From Operating Activities		$0.00	$0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4496872	usd
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-140200	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1145081	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001848861
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41145
	dei	Entity Registrant Name EntityRegistrantName	HEALTHCARE AI ACQUISITION CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1585450
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8 The Green
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste 15614
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dover
	dei	Entity Address State Or Province EntityAddressStateOrProvince	DE
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19901
	dei	City Area Code CityAreaCode	917
	dei	Local Phone Number LocalPhoneNumber	446-0469
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	591851	shares
CY2024Q2	us-gaap	Cash Cash	212	usd
CY2023Q4	us-gaap	Cash Cash	212	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	40500	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	0	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	40712	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	212	usd
CY2024Q2	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	0	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	0	usd
CY2024Q2	us-gaap	Investments And Cash InvestmentsAndCash	6750223	usd
CY2023Q4	us-gaap	Investments And Cash InvestmentsAndCash	6588790	usd
CY2024Q2	us-gaap	Assets Assets	6790935	usd
CY2023Q4	us-gaap	Assets Assets	6589002	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	235585	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	241064	usd
CY2024Q2	haia	Promissory Note Related Party Current PromissoryNoteRelatedPartyCurrent	216449	usd
CY2023Q4	haia	Promissory Note Related Party Current PromissoryNoteRelatedPartyCurrent	216449	usd
CY2024Q2	haia	Amount Due To Related Parties Current AmountDueToRelatedPartiesCurrent	340006	usd
CY2023Q4	haia	Amount Due To Related Parties Current AmountDueToRelatedPartiesCurrent	135745	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	792040	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	593258	usd
CY2024Q2	haia	Warrant Liability Non Current WarrantLiabilityNonCurrent	876246	usd
CY2023Q4	haia	Warrant Liability Non Current WarrantLiabilityNonCurrent	552035	usd
CY2024Q2	haia	Deferred Liabilities Noncurrent DeferredLiabilitiesNoncurrent	0	usd
CY2023Q4	haia	Deferred Liabilities Noncurrent DeferredLiabilitiesNoncurrent	0	usd
CY2024Q2	haia	Deferred Underwriting Commissions Non Current DeferredUnderwritingCommissionsNonCurrent	0	usd
CY2023Q4	haia	Deferred Underwriting Commissions Non Current DeferredUnderwritingCommissionsNonCurrent	0	usd
CY2024Q2	us-gaap	Liabilities Liabilities	1668286	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1145293	usd
CY2024Q2	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	6750223	usd
CY2023Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	6588790	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	362947	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	524380	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1991060	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1670000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-1627574	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1145081	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6790935	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6589002	usd
CY2024Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	70749	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	300773	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	158282	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	698705	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-70749	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-300773	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-158282	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-698705	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	76205	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	2134033	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	161433	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1588197	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	324211	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	602419	usd
CY2024Q2	haia	Change In Fair Value Of Over Allotment Liability ChangeInFairValueOfOverAllotmentLiability	0	usd
CY2023Q2	haia	Change In Fair Value Of Over Allotment Liability ChangeInFairValueOfOverAllotmentLiability	0	usd
	haia	Change In Fair Value Of Over Allotment Liability ChangeInFairValueOfOverAllotmentLiability	0	usd
	haia	Change In Fair Value Of Over Allotment Liability ChangeInFairValueOfOverAllotmentLiability	0	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	216405	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3722230	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-162778	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3894453	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	145656	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	3421457	usd
	us-gaap	Net Income Loss NetIncomeLoss	-321060	usd
	us-gaap	Net Income Loss NetIncomeLoss	3195748	usd
CY2024Q1	haia	Re Measurement Of Class A Ordinary Shares Subject To Possible Redemption ReMeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption	-85228	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-466716	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1697025	usd
CY2024Q2	haia	Re Measurement Of Class A Ordinary Shares Subject To Possible Redemption ReMeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption	-76205	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	145656	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-1627574	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8710136	usd
CY2023Q1	haia	Re Measurement Of Class A Ordinary Shares Subject To Possible Redemption ReMeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption	-2362839	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-225709	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-11298684	usd
CY2023Q2	haia	Conversion Of Class B Shares To Class A Shares Amount ConversionOfClassBSharesToClassASharesAmount	0	usd
CY2023Q2	haia	Re Measurement Of Class A Ordinary Shares Subject To Possible Redemption ReMeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption	-2134033	usd
CY2023Q2	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	524380	usd
CY2023Q2	haia	Forgive Of Deferred Underwriter Discount ForgiveOfDeferredUnderwriterDiscount	7546840	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	3421457	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1940040	usd
	us-gaap	Net Income Loss NetIncomeLoss	-321060	usd
	us-gaap	Net Income Loss NetIncomeLoss	3195748	usd
	haia	Interest Earned On Investments Held In Trust InterestEarnedOnInvestmentsHeldInTrust	161434	usd
	haia	Interest Earned On Investments Held In Trust InterestEarnedOnInvestmentsHeldInTrust	4496872	usd
	haia	Change In Warrant Liability ChangeInWarrantLiability	324211	usd
	haia	Change In Warrant Liability ChangeInWarrantLiability	602419	usd
	haia	Increase Decrease In Prepaid Assets IncreaseDecreaseInPrepaidAssets	40500	usd
	haia	Increase Decrease In Prepaid Assets IncreaseDecreaseInPrepaidAssets	-185730	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5479	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	24242	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	204261	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	57670	usd
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	0	usd
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	30000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-401063	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-401063	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	212	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	401275	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	211	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	212	usd
	haia	Accretion Of Class A Ordinary Shares Subject To Possible Redemption AccretionOfClassAOrdinarySharesSubjectToPossibleRedemption	161433	usd
	haia	Accretion Of Class A Ordinary Shares Subject To Possible Redemption AccretionOfClassAOrdinarySharesSubjectToPossibleRedemption	2362839	usd
	haia	Deferred Underwriting Payable Forgave DeferredUnderwritingPayableForgave	0	usd
	haia	Deferred Underwriting Payable Forgave DeferredUnderwritingPayableForgave	7546840	usd
	haia	Administrative Service Fee Forgave By Related Party Charge To Additional Paid In Capital AdministrativeServiceFeeForgaveByRelatedPartyChargeToAdditionalPaidInCapital	0	usd
	haia	Administrative Service Fee Forgave By Related Party Charge To Additional Paid In Capital AdministrativeServiceFeeForgaveByRelatedPartyChargeToAdditionalPaidInCapital	177095	usd
	haia	Deferred Offering Costs Assumed By Related Party Charge To Additional Paid In Capital DeferredOfferingCostsAssumedByRelatedPartyChargeToAdditionalPaidInCapital	0	usd
	haia	Deferred Offering Costs Assumed By Related Party Charge To Additional Paid In Capital DeferredOfferingCostsAssumedByRelatedPartyChargeToAdditionalPaidInCapital	347285	usd
	haia	Redemption Of Shares From Marketable Securities Held In Trust Account RedemptionOfSharesFromMarketableSecuritiesHeldInTrustAccount	0	usd
	haia	Redemption Of Shares From Marketable Securities Held In Trust Account RedemptionOfSharesFromMarketableSecuritiesHeldInTrustAccount	208992255	usd
	haia	Promissory Loan From Sponsor For Extension PromissoryLoanFromSponsorForExtension	0	usd
	haia	Promissory Loan From Sponsor For Extension PromissoryLoanFromSponsorForExtension	50000	usd
CY2024Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	2500000	usd
	haia	Threshold Minimum Aggregate Fair Market Value As Percentage Of Assets Held In Trust Account ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount	0.80	pure
	haia	Threshold Percentage Of Outstanding Voting Securities Of Target To Be Acquired By Post Transaction Company To Complete Business Combination ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination	0.50	pure
	haia	Threshold Period From Closing Of Initial Public Offering Company Is Obligated To Complete Business Combination ThresholdPeriodFromClosingOfInitialPublicOfferingCompanyIsObligatedToCompleteBusinessCombination	P18M
	haia	Number Of Business Days To Redeem Shares Upon Completion Of Initial Business Combination NumberOfBusinessDaysToRedeemSharesUponCompletionOfInitialBusinessCombination	two business days
CY2024Q2	us-gaap	Share Price SharePrice	10.20
	haia	Minimum Net Interest To Pay Dissolution Expenses MinimumNetInterestToPayDissolutionExpenses	100000	usd
CY2023Q3	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	1146276	shares
CY2023Q3	haia	Amount Removed From Trust Account AmountRemovedFromTrustAccount	12302385	usd
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.73
CY2023Q3	haia	Common Stock Shares Redemption CommonStockSharesRedemption	591851	shares
CY2023Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	6352029	usd
CY2024Q2	us-gaap	Cash Cash	212	usd
CY2023Q4	us-gaap	Cash Cash	212	usd
CY2024Q2	haia	Working Capital WorkingCapital	751328	usd
CY2023Q4	haia	Working Capital WorkingCapital	593046	usd
CY2023Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	50000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statement in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q2	us-gaap	Cash Cash	212	usd
CY2023Q4	us-gaap	Cash Cash	212	usd
CY2024Q2	haia	Cash And Investments Held In Trust Account CashAndInvestmentsHeldInTrustAccount	6750222	usd
CY2023Q4	haia	Cash And Investments Held In Trust Account CashAndInvestmentsHeldInTrustAccount	6588790	usd
CY2024Q2	haia	Stockholder Equity Other Shares StockholderEquityOtherShares	19824274	shares
CY2023Q4	haia	Stockholder Equity Other Shares StockholderEquityOtherShares	1146276	shares
CY2024Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.54
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.73
CY2023Q2	us-gaap	Amount Of Regulatory Costs Not Yet Approved AmountOfRegulatoryCostsNotYetApproved	208992255	usd
CY2023Q3	us-gaap	Amount Of Regulatory Costs Not Yet Approved AmountOfRegulatoryCostsNotYetApproved	12302385	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC Topic 815, “Derivatives and Hedging—Contracts in Entity’s Own Equity” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. In accordance with ASC Topic 825 “Financial Instruments,” offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statement of operations as incurred.</p>
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	21906161	shares
CY2024Q2	haia	Dissolution Expense DissolutionExpense	100000	usd
	haia	Amount Interest Bearing And Unsecured Promissory Note AmountInterestBearingAndUnsecuredPromissoryNote	1500000	usd
CY2024Q2	haia	Amount Due To Related Parties Current AmountDueToRelatedPartiesCurrent	340006	usd
CY2023Q4	haia	Amount Due To Related Parties Current AmountDueToRelatedPartiesCurrent	135745	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	10000	usd
CY2024Q2	haia	Accrued Sponsor Fees AccruedSponsorFees	177095	usd
CY2022Q4	haia	Accrued Sponsor Fees AccruedSponsorFees	127095	usd
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	177095	usd
	haia	Cash Underwriting Discount Percentage CashUnderwritingDiscountPercentage	0.020	pure
	haia	Underwriter Cash Discount UnderwriterCashDiscount	4312480	usd
	haia	Deferred Underwriting Discount Percentage DeferredUnderwritingDiscountPercentage	0.035	pure
	haia	Deferred Underwriter Discount Amount DeferredUnderwriterDiscountAmount	7546840	usd
CY2023Q2	haia	Deferred Underwriter Discount Amount DeferredUnderwriterDiscountAmount	7546840	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	21906161	shares
CY2024Q2	haia	Percentage Of Gross Proceeds On Equity Proceeds PercentageOfGrossProceedsOnEquityProceeds	0.60	pure
CY2024Q2	haia	Class Of Warrant Or Right Adjustment Of Exercise Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice	1.15	pure
CY2024Q2	haia	Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price One ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPriceOne	1.80	pure
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001

Files In Submission

Name	View Source	Status
0001477932-24-005453-index-headers.html	Edgar Link	pending
0001477932-24-005453-index.html	Edgar Link	pending
0001477932-24-005453.txt	Edgar Link	pending
0001477932-24-005453-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
haia-20240630.xsd	Edgar Link	pending
haia_10q.htm	Edgar Link	pending
haia_ex311.htm	Edgar Link	pending
haia_ex312.htm	Edgar Link	pending
haia_ex321.htm	Edgar Link	pending
haia_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
haia-20240630_cal.xml	Edgar Link	unprocessable
haia-20240630_def.xml	Edgar Link	unprocessable
haia-20240630_lab.xml	Edgar Link	unprocessable
haia-20240630_pre.xml	Edgar Link	unprocessable
haia_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HAIAF
Healthcare AI Acquisition Corp. Stock $haiaf

2024 Q3 Form 10-Q Financial Statement

#000147793224005453 Filed on September 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAIAF Healthcare AI Acquisition Corp. Stock $haiaf

2024 Q3 Form 10-Q Financial Statement

#000147793224005453 Filed on September 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAIAF
Healthcare AI Acquisition Corp. Stock $haiaf